![Charles L. Dimmler](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Charles L. Dimmler
Corporate Officer/Principal presso Newcastle Harbor LLC
Provenienza dei contatti di primo grado di Charles L. Dimmler
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Gene Logic, Inc.
![]() Gene Logic, Inc. BiotechnologyHealth Technology Gene Logic, Inc. provides drug discovery and development services to pharmaceutical and biotechnology companies worldwide. The company operates in three segments: Genomics and Toxicogenomics Services, Preclinical Contract Research Services, and Drug Repositioning and Selection Services. Gene Logic was incorporated in 1994 and is headquartered in Gaithersburg, Maryland.
30
| Extinct | Biotechnology | 30 |
PROMETHERA Biosciences SA
![]() PROMETHERA Biosciences SA Pharmaceuticals: MajorHealth Technology PROMETHERA Biosciences SA discovers, develops and commercializes cell therapy products to treat liver diseases. It operates as a pharmaceutical company that develops treatment based on allogeneic adult stem cell technology. The firm’s technology platform is based on a newly discovered cell type, isolated from normal human adult liver tissue: Heterologous Human Adult Liver Progenitor Cells (HHALPC). The company was founded by Etienne Marc Sokal and Eric Halioua on February 12, 2009 and is headquartered in Mont-Saint-Guibert, Belgium.
12
| Holding Company | Pharmaceuticals: Major | 12 |
Ore Pharmaceuticals, Inc.
![]() Ore Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ore Pharmaceuticals, Inc. operates as a drug development company, which developed drug candidates for therapeutic uses. The firm marketed its drug repositioning capabilities to pharmaceutical companies based in North America, Japan and Europe. The company was founded in September 1994 and was headquartered in Wellesley, MA.
3
| Extinct | Pharmaceuticals: Major | 3 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Charles L. Dimmler tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
ANACOMP, INC. | Information Technology Services | Director/Board Member | |
CURIS, INC. | Biotechnology | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Battelle Memorial Institute
![]() Battelle Memorial Institute Miscellaneous Commercial ServicesCommercial Services Battelle Memorial Institute operates as a science and technology development company. It offers services for government and commercial. The company was founded by Gordon Battelle in 1929 and is headquartered in Columbus, OH. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
MAXCYTE, INC. | Biotechnology | Chairman Corporate Officer/Principal | |
Bayer Pharmaceuticals Corp. | Corporate Officer/Principal Private Equity Investor | ||
Xceed Molecular Corp.
![]() Xceed Molecular Corp. Medical SpecialtiesHealth Technology Xceed Molecular Corporation is a molecular diagnostic company dedicated to commercializing a platform for automated gene expression analysis and developing proprietary clinical research assays and custom arrays. They develop tools and content aimed at accelerating the current market trend towards 'translational medicine', and bridging the gap from gene signature validation to clinical diagnostics. The Ziplex Automated Workstation is the first integrated and fully automated hybridization system for multiplex gene expression signatures. Their integrated solution - the Ziplex System - features this innovative instrument platform and focused-content TipChip arrays and reagents to perform highly multiplexed molecular assays with superior accuracy, reproducibility, speed and scalability. The Ziplex System is designed to provide the ease-of-use in assay automation and analytics that is required to successfully translate gene expression analysis from research use into routine practice. Xceed complements the Ziplex platform by offering Gene Expression Services and Assay Development Services. | Medical Specialties | Director/Board Member Chief Tech/Sci/R&D Officer | |
GOLDEN EAGLE RETAIL GROUP LIMITED | Department Stores | Corporate Secretary | |
TIGENIX NV | Medical Specialties | Director of Finance/CFO | |
Société Régionale d'Investissement de Wallonie SA
![]() Société Régionale d'Investissement de Wallonie SA Investment ManagersFinance Société Régionale d'Investissement de Wallonie SA (SRIW) is a private equity & venture capital firm , a subsidiary of Region of Wallonia founded in 1979. Société Régionale d'Investissement de Wallonie SA is headquartered in Liege, Belgium. | Investment Managers | Private Equity Investor | |
Boston University | College/University | Masters Business Admin Masters Business Admin | |
Smeets Securities BV | Corporate Officer/Principal | ||
GrowthWorks Capital Ltd.
![]() GrowthWorks Capital Ltd. Investment ManagersFinance GrowthWorks Capital Ltd. (GrowthWorks) is a venture capital firm founded in 1992 by David Levi. The firm is headquartered in Vancouver, Columbia with additionaal offices in Saskatchewan, Manitoba, New Brunswick, Newfoundland, Nova Scotia, and Ontario. | Investment Managers | Corporate Officer/Principal | |
Neurotech Pharmaceuticals, Inc. (United States)
![]() Neurotech Pharmaceuticals, Inc. (United States) Pharmaceuticals: MajorHealth Technology Neurotech Pharmaceuticals, Inc. designs and develops therapeutic systems for retinal diseases. The company was founded in 1995 and is headquartered in Cumberland, RI. | Pharmaceuticals: Major | Founder | |
Massachusetts Institute of Technology | College/University | Doctorate Degree Corporate Officer/Principal | |
The Johns Hopkins University | College/University | Graduate Degree Corporate Officer/Principal | |
University of Western Ontario | College/University | Undergraduate Degree | |
University of California, Berkeley | College/University | Doctorate Degree Graduate Degree | |
University of Cincinnati (Ohio) | College/University | Undergraduate Degree Doctorate Degree | |
The University of Colorado | College/University | Undergraduate Degree | |
University of Houston
![]() University of Houston Other Consumer ServicesConsumer Services University of Houston System offers higher education degrees and job training or vocational study programs. It offers about 280 undergraduate and graduate degree programs in fields such as business, education, humanities and law. It was founded in 1927 and is headquartered in Houston, TX. | College/University | Masters Business Admin | |
University of Maryland | College/University | Undergraduate Degree Doctorate Degree | |
Active Pass Pharmaceuticals, Inc.
![]() Active Pass Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Active Pass Pharmaceuticals, Inc. develops drugs for infectious diseases. It engages in the development of drugs that inhibit ABC transporters. The firm also provides portfolio of therapeutic programs, including age-related macular degeneration, travelers' diarrhea, and lipid disorders. The company was founded by Peter B Reiner in 1998 and is headquartered in Vancouver, Canada. | Pharmaceuticals: Major | Corporate Officer/Principal | |
EMERGENT BIOSOLUTIONS INC. | Pharmaceuticals: Major | Investor Relations Contact Public Communications Contact | |
Ogeda SA
![]() Ogeda SA Pharmaceuticals: MajorHealth Technology Ogeda SA discovers and develops small molecule drugs. It develops NK3 antagonists for the treatment of hormone-dependent pathologies in the field of Women's Health. The company was founded in 1994 and is headquartered in Gosselies, Spain. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
DMS IMAGING | Biotechnology | Chief Executive Officer Director/Board Member | |
Tc Land Expression SA
![]() Tc Land Expression SA Miscellaneous Commercial ServicesCommercial Services Tc Land Expression SA operates as a molecular diagnostic company. It focuses on the development and commercialisation of tests aimed at monitoring patients with immunological conditions. The firm specializes in the area of organ transplantation and immune mediated disorders. Its development programs encompass RA-INF-Dx, IMD Dx2, IMD Dx3, and L-TolX. The company was founded by Marina Guillet and Alain Huriez in November 2002 and is headquartered in Huningue, France. | Miscellaneous Commercial Services | Chief Executive Officer | |
Université Catholique de Louvain | College/University | Graduate Degree Doctorate Degree | |
ORE HOLDINGS INC | Financial Conglomerates | Chairman President Director/Board Member Chief Tech/Sci/R&D Officer | |
GlaxoSmithKline LLC
![]() GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
BioWin ASBL
![]() BioWin ASBL Miscellaneous Commercial ServicesCommercial Services BioWin ASBL operates as non-profit organization, with interest in the health biotechnology sector. With its member, the firm provides support for the funding in the research and development of biomarkers, nano medicine, drug delivery system, novel therapies, medical devices, and information technology applied to human health. The company is headquartered in Gosselies, Belgium. | Miscellaneous Commercial Services | Director/Board Member | |
ASLAN Pharmaceuticals Pte Ltd.
![]() ASLAN Pharmaceuticals Pte Ltd. BiotechnologyHealth Technology ASLAN Pharmaceuticals Pte Ltd. develops novel medicines for global markets. It licenses preclinical and early clinical compounds from global pharmaceutical companies, focusing on oncology, respiratory and inflammation diseases and uses the high quality and efficient development resources available across Asia to progress the drugs through clinical development. The company was founded by Carl Aslan Jason Morton Firth, Mark McHale and Jeffrey Tomlinson in 2010 and is headquartered in Singapore. | Biotechnology | Founder | |
Pharmacopae Biosciences | Corporate Officer/Principal | ||
Bridge2Health SA
![]() Bridge2Health SA BiotechnologyHealth Technology Bridge2Health SA provides biomedical translational research services. It offers services to the clinicians, basic researchers and pharmaceutical industries. The firm also provides blueprint for biobank query and retrieval between universities. The company was founded in September 2012 and is headquartered in Liege, Belgium. | Biotechnology | Director/Board Member | |
iSTAR Medical SA
![]() iSTAR Medical SA Medical SpecialtiesHealth Technology iSTAR Medical SA develops innovative ophthalmic implants. Its products include MINIject, STARflo and STAR Material. The company was founded by Michel Alvarez in 2011 and is headquartered in Wavre, Belgium. | Medical Specialties | Director/Board Member | |
Novadip Biosciences SA
![]() Novadip Biosciences SA BiotechnologyHealth Technology Novadip Biosciences SA operates as a advanced biopharmaceutical company that develops cell-based therapies to treat patients with critical size bone defects and severe bone diseases. Its proprietary product, Creost, is a natural scaffold-free and tridimensional bone structure, which reconstructs large bone defects without the need of any biomaterial. The firm is a osteogenic living implant with a mineralization similar to a real bone. Its Creost is an autologous cell based-therapy product obtained from Adipose-derived Mesenchymal Stem Cells (AMSCs) which promotes (i) a perfect engraftment without any scaffold and (ii) a tissue remodeling with all native bone properties. Novadip Biosciences was founded by Jean-Fran?ois Pollet and Denis Dufrane in 2013 and is headquartered in Louvain-la-Neuve, Belgium. | Biotechnology | Director/Board Member | |
CUE BIOPHARMA, INC. | Biotechnology | Chief Executive Officer Corporate Officer/Principal | |
Ncardia SA
![]() Ncardia SA Miscellaneous Commercial ServicesCommercial Services Ncardia SA engages in drug discovery research and development. Its cardiac products encompass hiPSC-derived Pluricyte, Cardiomyocytes, Cor.4U cardiomyocytes and vCor.4U ventricular cardiomyocytes and FibroCor.4U cardiac fibroblasts. The company is headquartered in Gosselies, Belgium. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
ASLAN PHARMACEUTICALS LIMITED | Biotechnology | Founder | |
Aslan Pharmaceuticals Taiwan Ltd.
![]() Aslan Pharmaceuticals Taiwan Ltd. BiotechnologyHealth Technology Part of Aslan Pharmaceuticals Ltd., Aslan Pharmaceuticals Taiwan Ltd. develops novel medicines. The company is based in Taipei, Taiwan and was founded in 2014. | Biotechnology | Director/Board Member |
Statistiche
Distribuzione geografica
Stati Uniti | 20 |
Belgio | 14 |
Canada | 5 |
Francia | 5 |
Singapore | 4 |
Settori
Health Technology | 22 |
Consumer Services | 11 |
Commercial Services | 6 |
Finance | 6 |
Technology Services | 2 |
Posizioni
Director/Board Member | 137 |
Corporate Officer/Principal | 79 |
Undergraduate Degree | 26 |
President | 21 |
Doctorate Degree | 19 |
Contatti più connessi
Insiders | |
---|---|
Jean-Paul Prieels | 32 |
Frank Douglas | 29 |
Lloyd I. Miller | 25 |
Chi Tak Fok | 16 |
Lou Tartaglia | 15 |
J. Stark Thompson | 14 |
Robert Proulx | 12 |
Jeffrey Tomlinson | 10 |
John Tchelingerian | 10 |
David L. Urdal | 9 |
David Weinreich | 9 |
Daniel Passeri | 9 |
Mark Gabrielson | 9 |
Michael J. Brennan | 9 |
Philippe Degive | 8 |
- Borsa valori
- Insiders
- Charles L. Dimmler
- Connessioni Società